Sven Binder BioNTech is most recently known for its mRNA COVID-19 vaccine which was approved in December 2020. This great accomplishment, however, was challenged by the obstacle of limited global manufacturing. Currently, vaccines are only being manufactured … Read more
For aspiring startups, scoring investors’ offers tend to be highly selective processes, calling for founding teams to be targets of due diligence from firms. In particular, they often do “founder diligence”, which is an evaluation … Read more
Interesting read for the week: Nature’s seven life science technologies to watch in 2022. What technologies are likely to impact life science in 2022? In this Nature article by Michael Einstein, he explores seven technologies … Read more
2021 has been an amazing year for LabBench2Business! We want to say thank you to our clients, our advisory board, our partners and everybody who supports us and opens doors for us! We wish everyone … Read more
The start-up ecosystem of Germany can become an essential part of the country’s growth engine by 2030, according to a new study by @McKinsey. Startups newly founded by 2030 could contribute an estimated nearly 2.3 … Read more
This week, our co-founder Sven Binder was invited to participate in the Biotech & Life Science Meetup in Mainz and moderated a session on financing possibilities for Life Science start-ups. Two ministers from Rhineland-Palatinate (Daniela Schmitt and Clemens … Read more
In recent years it has been observed that most of the novel discoveries in the field of biotechnology have been made by smaller companies and start-ups. The products, however, are often brought to the market … Read more
The 8th Edition of the German Startup Monitor presents some interesting findings with regards to how the Corona pandemic has affected the mentality of startups in Germany. The collected data gives a clear picture of … Read more
Frankfurt am Main is the fifth largest city in Germany, located in one of the largest economic regions in Germany and well known for its financial sector with more than two hundred banks, PE’s, VC’s … Read more
Interesting look into Novo Holdings which ranks among the world’s most active life sciences investors. Some highlights from the Sifted article: ● Novo Holdings fund made 33 new investments and 65 follow-on investments in life … Read more